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This paper begins to address the international regulation of emerging technologies taking 
an approach that includes the co-production of technologies and the nature of wicked 
problems. Both the development of technologies over time, the role of science in regulation, 
and results from case studies in the regulation of biotechnologies are discusses. 
Biotechnology, nanotechnology and synthetic biology receive the most attention. 
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	exogenous.29	The	problem	is	an	old	one.	What	looks	good	in	theory,	encounters	problems	
when	put	into	practice,	and	the	reality	may	be	more	complex	than	it	was	hoped	for.		
	
Academics,	farmers,	activists,	multinational	corporations,	government	officials	all	promote	
their	views	on	the	advantages	of	technology	or	its	regulation,	however	when	it	comes	to	GM	
crops	“the	scientific	data	are	often	inconclusive	or	contradictory”.30	In	2013	a	record	of	175.2	
million	hectares	of	biotech	crops	were	grown	globally.31		Meanwhile	a	bit	of	dust	has	started	to	
accumulate	on	some	of	earlier	texts	on	the	international	aspects	of	genetically	modified	
organisms	(GMO),		and	one	wonders	how	these	narratives	compare	with	local	farmer’s	
realities.		
	The	Local	Headaches	
	
Let’s	take	the	case	of	GM	cotton	which	constitutes	a	large	fraction	of	the	total	global	
production	of	all	of	GM	crops.	The	estimate	is	that	in	the	US	more	than	90	per	cent	of	the	
planted	cotton	is	2014	was	GM.32	In	Argentina	the	estimate	is	that	it	covers	about	80-90	per	
cent	of	the	area	sown	albeit	with	uncertified	transgenic	seed.33Briefly,	there	are	three	main	
types	of	GM	cotton	varieties	based	on	two	different	genetic	traits:	one	is	resistant	to	the	
herbicide	glyphosate	(also	known	by	Monsanto’s	trademark	Roundup),	another	produces	
toxins	that	kill	cotton	bollworm.	The	tree	types	of	GM	cotton	on	the	market	are:	one	that	is	
glyphosate	resistant,	one	that	produces	the	Bt	toxin,	and	a	third	incorporating	both	traits.	Over	
fifty	different	commercial	GM	cotton	seeds	have	been	approved.	The	seeds	trade	names	and	
details	are	available	in	databases	such	as	those	maintained	by	the	International	Service	for	the	
Acquisition	of	Agri-Biotech	Applications	34,	GMO	Compass.35	The	International	Cotton	Advisory	
Committee36	provides	statistics	on	world	cotton	production,	consumption,	trade,	and	serves	as	
																																								 																				
29	Michael	Howlett	and	Andrea	Mignone,	‘Regulatory	Lifecycles	and	Comparative	
Biotechnology	Regulation’,	in	Regulating	Next	Generation	Agri-Food	Bio-Technologies,	
ed.	Michael	Howlett	and	David	Laycock	(Routledge,	2013),	64.	
30	Natasha	Gilbert,	‘Case	Studies:	A	Hard	Look	at	GM	Crops’,	Nature	497,	no.	7447	(1	
May	2013):	24–26.	
31	Clive	James,	‘Global	Status	of	Commercialized	Biotech/GM	Crops:	2013	-	ISAAA	Brief	
46-2013:	Executive	Summary’,	International	Service	for	the	Acquisition	of	Agri-Biotech	
Applications,	2014,	
http://www.isaaa.org/resources/publications/briefs/46/executivesummary/.	
32	http://www.ers.usda.gov/data-products/adoption-of-genetically-engineered-crops-
in-the-us/recent-trends-in-ge-adoption.aspx		
33	Maria-Eugenia	Fazio	et	al.,	‘Local	Realities	for	Transgenic	Cotton’,	in	Regulating	
Technology:	International	Harmonization	and	Local	Realities,	ed.	Patrick	Van	
Zwanenberg,	Adrian	Ely,	and	Adrian	Smith	(London ;	Washington,	DC:	Earthscan,	
2011),	73–98.	
34	http://www.isaaa.org/	
35	http://www.gmo-compass.org/	
36	https://www.icac.org/	
	a	clearing	house	for	technical	information	about	cotton	and	cotton	textiles;	it	also	represents	
the	international	cotton	industry	before	UN	agencies	and	other	international	organizations.	
	
In	theory	and	in	the	laboratory,	but	also	from	an	ideological	point	of	view,	great	opportunities	
for	better	integration	of	conventional	breeding	and	molecular	biology	to	improve	cultivars	and	
herald	a	new	age	in	cotton	improvement	seem	promising.37	It	is	claimed	that	80%	of	global	
cotton	production	in	2012	was	that	from	genetically	modified	seeds38	The	reality	on	the	
ground	tells	a	different	story.		
	
In	the	global	south,	one	study	in	the	Chaco	province	in	Argentina	what	was	found	was	that	
only	the	2	per	cent	of	farmers	with	more	than	200	hectares	of	land	and	producing	70	per	cent	
of	the	cotton	had	both	the	means	to	buy	certified	transgenetic	seed	and	both	the	knowledge	
and	scale	to	maintain	quality	of	successive	multiplications	of	saved	seed.39	To	add	insult	to	
injury,	the	‘2	per	cent	farmers’	are	also	adept	at	ignoring	contracts	that	would	bind	them	to	
take	recommended	measures	to	maintain	the	quality	of	the	new	seed	and	to	delay	
development	of	pest	resistance	to	the	Bt	toxin	while	the	majority	in	the	same	region	who	
obtain	non-certified	seeds	in	informal	markets	have	neither	the	gins	to	delint	the	seeds	nor	the	
knowledge	to	ensure	quality	or	make	the	best	of	what	they.40	That	is,	the	majority	of	these	
Argentinian	small	cotton	farmers	get	seeds	of	not	only	variable,	but	doubtful	quality	with	
transgenic	and	non-transgenic	traits,	and	due	to	the	lack	of	knowledge	or	mislabelling	farmers	
end	up	with	poor	yields	as	may	be	case	if	a	herbicide	resistance	is	assumed	when	instead	the	
non-certified	seed	is	pesticide	resistant.	That	is,	these	small	cotton	farmers	are	beyond	the	
reach	of	the	regulatory	regime.	In	this	case,	the	local	regulatory	agency	–	the	Insituto	Nacional	
de	Semillas	(INASE)	–	is	practically	incapable	of	asserting	any	oversight	especially	in	informal	
markets,	but	also	there	where	farmers	ignore	contractual	obligations	although	their	task	is	
that	of	applying	the	Seed	Law	(Ley	de	Semillas	Y	Creaciones	Fitogenéticas	N°	20.247).	The	
resulting	situation	is	one	where	regulation	of	the	technology	fails	at	several	levels	beyond	the	
international	modalities	that	made	it	possible	for	the	seed	to	enter	the	market.	The	interests	
of	those	whom	the	technology	ought	to	benefit	are	left	unattended	by	local	and	national	
governments.	The	rights,	moral	and	ethical	values	recognized	by	international	law	are	
orphaned.		
	
This	situation	also	raises	question	of	biosafety	and	biodiversity.	The	fact	that	uncontrolled	GM	
seeds	reach	the	informal	markets	without	biosafety	testing	and	approval,	leaves	open	the	
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	question	of	“regulatory	capacity	to	anticipate	and	diminish	potential	environmental	impacts,	
or	to	assure	international	markets	that	exported	products	are	what	they	purport	to	be”.41	
	
In	the	provinces	of	Hubei	and	Shandong	in	China	the	sociotechnical	dynamics	are	different	
from	those	in	the	Chaco	proving	in	Argentina,	and	correspondingly	the	regulatory	failures	are	
different.	Using	nationally	representative	panel	data,	Arza	and	van	Zwanenberg	analysed	the	
economic	impact	of	Bt	cotton	adoption	and	its	sustainability,	after	15	years	of	its	
commercialization	in	China.	Consistent	with	its	short-term	impact,	the	study	they	showed	that	
the	economic	benefit	of	Bt	cotton	did	not	diminish,	but	remained	stable	and	continuous	in	
China.42	Their	study	that	uses	nationally	representative	data	and	focuses	on	the	economic	
benefit	of	Bt	cotton	and	its	dynamics.	“As	shown	in	this	paper,	the	first	generation	of	cotton	
varieties	with	a	single	Bt	gene	still	can	effectively	control	the	bollworm.	Even	though	farmers	in	
some	countries	have	switched	from	unpatented	and	royalty	fee	cotton	varieties	with	a	single	
Bt	gene	to	patented	cotton	varieties	with	stacked	genes,	rigorous	analysis	is	needed	to	answer	
whether	this	switch	is	economical	or	a	result	caused	by	many	factors	.”43			
The	patterns	described	for	“international	transfer	to	and	adaptation	of	genetically	modified	
(GM)	cotton	in	Argentina,	and	ask	whether	political	bargaining	between	the	technology	owner,	
a	multinational	enterprise	(MNE),	and	host	country	actors	may	have	influenced	upgrading”	to	
GM	crops.	These	authors	suggest	that	“the	MNE	was	able	to	use	its	exclusive	capacity	to	
upgrade	GM	cotton	technologies	as	a	negotiation	tool	to	persuade	host	actors	to	change	the	
rules	that	affected	its	multiple	line	of	business	in	the	country.	This	implies	wider	policy	scope	
to	encourage	technology	upgrading;	host	actors	could	negotiate	over	a	wider	range	of	aspects	
of	interest	to	MNEs.”44			
	
That	there	many	more	problems	to	be	addressed	beyond	the	interests	of	multinational	
corporations	ought	to	be	evident.	That	is,	“despite	the	widespread	adoption	of	Bt	crops	and	a	
continued	increase	in	the	area	on	which	they	are	grown,	there	are	still	a	number	of	
unanswered	questions	associated	with	longer	term	agro-ecosystem	interactions,	for	instance	
the	impact	of	secondary	pests.”45		
Meanwhile	the	situation	is	not	optimal	in	the	global	north	either	even	if	the	problems	have	a	
different	character.	In	the	US	the	annual	statistics	for	1992	to	2009	on	cotton	planted	indicates	
that	while	the	percentage	of	genetically	modified	cotton	has	increased	to	nearly	90	per	cent,	
the	average	annual	total	herbicide	application	rate	for	cotton	(mass	per	area)	fails	to	show	a	
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	decrease	although	it	would	have	been	expected	according	to	theory	and	rationale	of	
introducing	transgenetic	traits.46		
	Regulation	and	Governance	Dreamscapes	
	
Nanotechnologies,	like	other	proceeding	technologies,	have	gotten	much	attention	and	a	too	
large	body	of	literature	has	been	generated	displaying	a	spectrum	of	views.	There	is	some	
agreement	that	there	are	two	main	dangers.	One	is	that	a	“blinkered	adherence	to	science-
driven	and	hierarchical	decision-making	approach”	in	regulation	will	ignore	the	values	of	the	
citizens	who	seek	to	influence	regulation	by	some	participative	or	other	legitimizing	
mechanisms.47	Another	is	that	perceptions	counter	to	current	scientific	understanding	may	
have	an	undue	or	non-justifiable	influence	on	regulatory	decisions.48	That	is,	balance	is	
required,	and	social,	regulatory	and	governance	innovation	is	called	upon	to	assure	
transparency,	legitimacy	and	trust	in	the	regulatory	process.	
	
	
	“We	have	come	to	the	point	in	synthetic	biology	where	there	are	many	lab-scale	or	proof-of-
concept	examples	of	chemically	controlled	systems	useful	to	sense	small	molecules,	treat	
disease,	and	produce	commercially	useful	compounds.	These	systems	have	great	potential,	but	
more	attention	needs	to	be	paid	to	their	stability,	efficacy,	and	safety.”49	(link	to	case	studies	
where	appropriate)	
	
Gervais	analysis	uses	a	classification	of	technology	that	is	interesting	as	an	analytical	tool,	and	
relies	mainly	on	the	precautionary	principle	application	to	leave	the	emerging	technology	
unregulated	and	pleads	for	a	nimble	regulatory	approach	(courts,	regulatory	agencies)	when	
risks	emerge.50	This	proposed	approach	ignores	the	nature	of	technology	and	co-production.	
(to	be	expanded)	
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Harmonization	presumes	stable	and	widely	shared	goals.	Develop.	“How	do	harmonizing	
regulations	impact	on	the	opportunities	for	poorer	communities	in	developing	countries	to	
effectively	access	new	technologies,	assure	themselves	of	benefits,	whilst	guarding	against	
risks?	How	do	harmonizing	regulations	affect	the	capacity	of	poorer	communities,	local	and	
national	businesses,	and	national	governments	to	develop	locally	appropriate	forms	of	
technology	use?	Do	regulations	enable	environmentally	sustainable	and	socially	just	
technology	development	pathways	appropriate	to	specific	situations	or	do	they	hinder	
them?”51		
Last	but	not	least,	there	is	the	issue	of	what	can	WTO	do	to	deal	with	emerging	technologies.	
The	verdict	is	that	if	an	analysis	(type)	of	the	EU	GM	regulation	in	light	of	the	WTO	trade	
disputes	is	indeed	legal,	but	it	certainly	has	been	costly.52	Then	when	looked	at	in	detail,	while	
WTO	and	international	law	cannot	really	ease	the	burden	of	dealing	with	wicked	regulatory	
and	governance	problems,	a	streamlining	of	its	functions	could	be	helpful	is	reducing	of	of	the	
burdens.	(to	be	developed,	TBT	is	what	is	on	the	line,	it	is	about	standards	after	all).		
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